We found that the glycosyltransferase beta-1,4-galactosyltransferase 1 (B4GALT1) was one of the top hits whose expression level was significantly decreased upon RBMS1 depletion in breast cancer cells (Figs. 4A and S4A–B). This evidence concerns the gene B4GALT4 and breast carcinoma.